• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎(NASH)与肝细胞癌(HCC)的自然病史。

Natural history of NASH and HCC.

作者信息

Negro Francesco

机构信息

Divisions of Gastroenterology and Hepatology and of Clinical Pathology, University Hospitals, Geneva, Switzerland.

出版信息

Liver Int. 2020 Feb;40 Suppl 1:72-76. doi: 10.1111/liv.14362.

DOI:10.1111/liv.14362
PMID:32077608
Abstract

Widespread unhealthy dietary habits associated with a sedentary lifestyle have made NAFLD the most frequent chronic liver disease worldwide, with a global prevalence of ~25%. Although NAFLD is mainly considered to be a benign disease, it can progress to severe liver fibrosis and hepatocellular carcinoma (HCC), with the latter found in non-cirrhotic livers in about 40% of cases. Factors favouring the progression of liver disease in NAFLD are only partially understood. Male sex, older age and Caucasian ethnicity have frequently been identified as factors accelerating the progression of fibrosis in NAFLD, although data are not consistent. Host genetic variants appear to be very important, especially in the gene coding for the patatin-like phospholipase domain-containing 3 (PNPLA3), and they may also play a role in the development of HCC, independent of activity and the extent of liver damage. However, the most important factors affecting disease progression are found in the metabolic syndrome, that is, obesity, type 2 diabetes and arterial hypertension. This mini-review will discuss the contribution of these factors to NAFLD-associated morbidity, emphasizing the importance of preventive measures such as physical activity and weight control in view of the current pandemic of the metabolic syndrome.

摘要

与久坐不动的生活方式相关的广泛存在的不健康饮食习惯,已使非酒精性脂肪性肝病(NAFLD)成为全球最常见的慢性肝病,全球患病率约为25%。尽管NAFLD主要被认为是一种良性疾病,但它可进展为严重肝纤维化和肝细胞癌(HCC),约40%的病例在非肝硬化肝脏中发现后者。NAFLD中有利于肝病进展的因素仅得到部分理解。男性、老年和白种人常被确定为加速NAFLD纤维化进展的因素,尽管数据并不一致。宿主基因变异似乎非常重要,尤其是在编码含帕他汀样磷脂酶结构域3(PNPLA3)的基因中,并且它们可能在HCC的发生发展中也起作用,独立于肝脏损伤的活动度和程度。然而,影响疾病进展的最重要因素存在于代谢综合征中,即肥胖、2型糖尿病和动脉高血压。本综述将讨论这些因素对NAFLD相关发病率的影响,鉴于当前代谢综合征的流行,强调诸如体育活动和体重控制等预防措施的重要性。

相似文献

1
Natural history of NASH and HCC.非酒精性脂肪性肝炎(NASH)与肝细胞癌(HCC)的自然病史。
Liver Int. 2020 Feb;40 Suppl 1:72-76. doi: 10.1111/liv.14362.
2
Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.非酒精性脂肪性肝病、代谢风险因素与肝细胞癌:一个悬而未决的问题。
World J Gastroenterol. 2015 Apr 14;21(14):4103-10. doi: 10.3748/wjg.v21.i14.4103.
3
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.非肝硬化非酒精性脂肪性肝病和代谢综合征背景下的肝细胞癌:美国的经验
Dig Dis Sci. 2015 Oct;60(10):3142-8. doi: 10.1007/s10620-015-3821-7. Epub 2015 Aug 7.
4
Non-alcoholic fatty liver disease associated with hepatocellular carcinoma: An increasing concern.非酒精性脂肪性肝病相关肝细胞癌:日益受到关注。
Indian J Med Res. 2019 Jan;149(1):9-17. doi: 10.4103/ijmr.IJMR_1456_17.
5
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.非酒精性脂肪性肝病/非酒精性脂肪性肝炎与肝细胞癌。
Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014.
6
Screening and interventions to prevent nonalcoholic fatty liver disease/nonalcoholic steatohepatitis-associated hepatocellular carcinoma.筛查和干预措施以预防非酒精性脂肪性肝病/非酒精性脂肪性肝炎相关肝细胞癌。
World J Gastroenterol. 2023 Jan 14;29(2):286-309. doi: 10.3748/wjg.v29.i2.286.
7
Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.20年间接受肝切除手术的非酒精性脂肪性肝病相关肝癌患者的时间趋势、临床模式及预后
Aliment Pharmacol Ther. 2017 Nov;46(9):856-863. doi: 10.1111/apt.14261. Epub 2017 Aug 31.
8
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
9
Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的流行病学:对肝移植的影响。
Transplantation. 2019 Jan;103(1):22-27. doi: 10.1097/TP.0000000000002484.
10
Epidemiology of non-alcoholic fatty liver disease in Asia.亚洲非酒精性脂肪性肝病的流行病学
Indian J Gastroenterol. 2020 Feb;39(1):1-8. doi: 10.1007/s12664-020-01018-x. Epub 2020 Mar 9.

引用本文的文献

1
() rs738409 Variant and Non-Alcoholic Fatty Liver Disease Risk in Vietnamese Working-Age Adults: A Case-Control Study with Metabolic Insights.越南劳动年龄成年人中 rs738409 变异与非酒精性脂肪性肝病风险:一项具有代谢见解的病例对照研究
Clin Exp Gastroenterol. 2025 Aug 29;18:191-204. doi: 10.2147/CEG.S532528. eCollection 2025.
2
Geographic diversity of human liver cancers mirrors global social inequalities.人类肝癌的地理多样性反映了全球社会不平等现象。
Front Oncol. 2025 May 16;15:1565692. doi: 10.3389/fonc.2025.1565692. eCollection 2025.
3
Metabolic dysfunction-associated steatotic liver disease in adults.
成人代谢功能障碍相关脂肪性肝病
Nat Rev Dis Primers. 2025 Mar 6;11(1):14. doi: 10.1038/s41572-025-00599-1.
4
Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena.非酒精性脂肪性肝病的发展:一种多因素致病现象。
Liver Res. 2022 May 19;6(2):72-83. doi: 10.1016/j.livres.2022.05.002. eCollection 2022 Jun.
5
Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential.细胞外囊泡在脂肪变性相关肝病中的作用及其治疗潜力。
World J Hepatol. 2024 Sep 27;16(9):1211-1228. doi: 10.4254/wjh.v16.i9.1211.
6
Neutrophil extracellular traps in homeostasis and disease.中性粒细胞胞外陷阱在稳态和疾病中的作用。
Signal Transduct Target Ther. 2024 Sep 20;9(1):235. doi: 10.1038/s41392-024-01933-x.
7
Quantifying the natural growth rate of hepatocellular carcinoma: A real-world retrospective study in southwestern China.量化肝细胞癌的自然生长率:中国西南部的一项真实世界回顾性研究。
World J Hepatol. 2024 May 27;16(5):800-808. doi: 10.4254/wjh.v16.i5.800.
8
From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences.从非酒精性脂肪性肝病到非酒精性脂肪性肝炎:了解非酒精性肝病的范围及其后果。
Heliyon. 2024 Apr 25;10(9):e30387. doi: 10.1016/j.heliyon.2024.e30387. eCollection 2024 May 15.
9
Matrix viscoelasticity promotes liver cancer progression in the pre-cirrhotic liver.基质粘弹性促进肝硬化前肝脏中的肝癌进展。
Nature. 2024 Feb;626(7999):635-642. doi: 10.1038/s41586-023-06991-9. Epub 2024 Jan 31.
10
Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers.感染因子导致原发性肝癌中Wnt/β-连环蛋白信号通路失调。
Microorganisms. 2023 Jun 22;11(7):1632. doi: 10.3390/microorganisms11071632.